![]() ![]() | VANDAMME, A., Schots, R., & BEGUIN, Y. (2012). Academic clinical trials run by the transplant committee of the Belgian Hematological Society. Belgian Journal of Hematology, 3 (2), 62-67. ![]() |
![]() ![]() | Springael, C., Thomas, S., Rahmouni, S., Vandamme, A., Goldman, M., Willems, F., & Vosters, O. (15 February 2007). Rottlerin inhibits human T cell responses. Biochemical Pharmacology, 73 (4), 515-525. doi:10.1016/j.bcp.2006.10.034 ![]() |
![]() ![]() | Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72 ![]() |
![]() ![]() | Zeddou, M., Rahmouni, S., VANDAMME, A., Schaaf-Lafontaine, N., & Moutschen, M. (2006). HIV viraemic patients downregulate CD94/NKG2A inhibitory receptors on NK as well as CD8 T cells in comparison with aviraemic counterparts [Poster presentation]. AIDS 2006 - XVI International AIDS Conference. |
Moutschen, M., VANDAMME, A., de valensart, N., Zeddou, M., & Rahmouni, S. (2006). Suboptimal engagement of CD28 during activation of naïve CD8 T cells induces the expression of the inhibitory heterodimer CD94/NKG2A [Paper presentation]. 7th EFIS Tatra Immunology Conference: molecular determinants of T-cell immunity, Štrbské Pleso, Slovakia. ![]() |